Skip to main content

Adipocytes, Adipocytokines, and Cancer

  • Chapter
  • First Online:
Adipocytokines, Energy Balance, and Cancer

Part of the book series: Energy Balance and Cancer ((EBAC,volume 12))

Abstract

Obesity is now a well-established promoter of cancer progression and decreased overall patient survival. Ever since the association between obesity and cancer was appreciated, adipose tissue, adipocytes, and secreted fat-derived factors have been a focus of the mechanism underlying this link. Adipose-secreted factors cytokines are referred to as adipocytokines and represent the group of molecules thought to link adipose or fat cells to initiation and promotion of various cancers. There are over 20 identified adipokines, of which, a subset has been implicated in cancer. In this chapter, we will provide a concise review of the current literature on the subset of adipose-derived factors linked to cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sethi JK, Vidal-Puig AJ (2007) Thematic review series: adipocyte biology.Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48:1253–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Diedrich J, Gusky HC, Podgorski I (2015) Adipose tissue dysfunction and its effects on tumor metabolism. Horm Mol Biol Clin Investig 21(1):17–41

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 19:109–124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ogden CL, Carroll M, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  6. Jones DH, Nestore M, Henophy S, Cousin J, Comtois AS (2014) Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure. Springerplus 3:150

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wolin KY, Carson K, Colditz GA (2010) Obesity and cancer. Oncologist 15:556–565

    Article  PubMed  PubMed Central  Google Scholar 

  8. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: a cohort study. Br Med J 355:1314

    Google Scholar 

  9. Booth A, Magnuson A, Fouts J, Foster M (2015) Adipose tissue, obesity, and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig 21(1):57–74

    CAS  PubMed  Google Scholar 

  10. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91

    Article  CAS  PubMed  Google Scholar 

  11. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(11 Suppl 1):S64–S73

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432

    Article  CAS  PubMed  Google Scholar 

  13. Muoio DM, Dohm G, Tapscott EB, Coleman RA (1999) Leptin opposes insulin’s effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol 276(5 Pt 1):E913–E921

    CAS  PubMed  Google Scholar 

  14. Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Beane Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF Jr, Curtis RE, Berrington de Gonzalez A, Morton LM (2014) Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol 32:4004–4011

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bhaskaran K, Douglas I, Forbes H, dos-Santos Silva I, Leon DA, Smeeth L (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765

    Article  PubMed  PubMed Central  Google Scholar 

  16. Garcia-Robles MJ, Segura-Ortega J, Fafutis-Morris M (2013) The biology of leptin and its implications in breast cancer: a general view. J Interferon Cytokine Res 33:717–727

    Article  CAS  PubMed  Google Scholar 

  17. Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, Hamnvik OP, Koniaris A (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567–E584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47:33–43

    Article  CAS  PubMed  Google Scholar 

  19. Vona-Davis L, Rose D (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206

    Article  CAS  PubMed  Google Scholar 

  20. Zheng Q, Dunlap S, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O (2011) Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer 18(4):491–503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zheng Q, Banaszak L, Fracci S, Basali D, Dunlap SM, Hursting SD, Rich JN, Hilemeland AB, Vasanji A, Berger NA, Lathia JD, Reizes O (2013) Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer 20:797–808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tewari R, Rajender S, Natu SM, Goel A, Dalela D, Goel MM, Tondon P (2013) Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men—a cross-sectional study. Cytokine 63:130–134

    Article  CAS  PubMed  Google Scholar 

  23. Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD (2014) Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer 110:1525–1534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Dong Z, Fu S, Xu X, Yang Y, Du L, Li W, Kan S, Li Z, Zhang X, Wang L, Li J, Liu H, Qu X, Wang C (2014) Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. Br J Cancer 110:1801–1810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S (2007) Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 60(8):902–906

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yehuda-Shnaidman E, Nimri L, Tarnovscki T, Kirshtein B, Rudich A, Schwartz B (2013) Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells. PLoS One 8, e74843

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Xiong Y, Zhang J, Liu M, An M, Lei L, Guo W (2014) Human leptin protein activates the growth of HepG2 cells by inhibiting PERK mediated ER stress and apoptosis. Mol Med Rep 10:1649–1655

    CAS  PubMed  Google Scholar 

  28. Kadowaki T, Yamauchi T (2015) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451

    Article  Google Scholar 

  29. Yamauchi N, Takazawa Y, Maeda D, Hibiya T, Tanaka M, Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T, Fukayama M (2012) Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues. Int J Gynecol Pathol 31:352–357

    Article  PubMed  Google Scholar 

  30. Grossmann ME, Nkhata K, Mizuno NK, Ray A, Cleary MP (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370–379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271–279

    Article  CAS  PubMed  Google Scholar 

  32. Wang Y, Lam K, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280:18341–18347

    Article  CAS  PubMed  Google Scholar 

  33. Goktas S, Yilmaz M, Caglar K, Sonmez A, Kilic S, Bedir S (2005) Prostate cancer and adiponectin. Urology 65:1168–1172

    Article  PubMed  Google Scholar 

  34. Bub JD, Miyazaki T, Iwamoto Y (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 340:1158–1166

    Article  CAS  PubMed  Google Scholar 

  35. Alexandre L, Long E, Beales IL (2014) Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol 5:534–549

    Article  PubMed  PubMed Central  Google Scholar 

  36. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H (2010) Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol 45:918–927

    Article  CAS  PubMed  Google Scholar 

  37. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y (2010) Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101:1286–1291

    Article  CAS  PubMed  Google Scholar 

  38. Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S, Mantzoros CS (2011) Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Mol Cancer Ther 10:2234–2243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Erdogan S, Sezer S, Baser E, Gun-Eryilmaz O, Gungor T, Uysal S, Yilmaz FM (2013) Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer. Endocr Relat Cancer 20:669–675

    Article  CAS  PubMed  Google Scholar 

  40. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14:1431–1437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Preiss J, Handler P (1957) Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 225:759–770

    CAS  PubMed  Google Scholar 

  42. Rongvaux A, Shea R, Mulks MH, Gigot D, Urbain J, Leo O, Andris F (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32:3225–3234

    Article  CAS  PubMed  Google Scholar 

  43. Chen MP, Chung F, Chang DM, Tsai JCR, Huang HF, Shin SJ, Lee YJ (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295–299

    Article  CAS  PubMed  Google Scholar 

  44. Andrade-Oliveira V, Camara NO, Moraes-Vieira PM (2015) Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res 2015:681612

    Article  PubMed  PubMed Central  Google Scholar 

  45. Yun MR, Seo J, Park HY (2014) Visfatin contributes to the differentiation of monocytes into macrophages through the differential regulation of inflammatory cytokines in THP-1 cells. Cell Signal 26(4):705–715

    Article  CAS  PubMed  Google Scholar 

  46. Huang WS, Chen C, Sze CI, Teng CC (2013) Visfatin induces stromal cell-derived factor-1 expression by beta1 integrin signaling in colorectal cancer cells. J Cell Physiol 228:1017–1024

    Article  CAS  PubMed  Google Scholar 

  47. Bułdak RJ, Buldak L, Polaniak R, Kukla M, Birkner E, Kubina R, Kabała-Dzik A, Duława-Bułdak A, Żwirska-Korczala K (2013) Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep 29:771–778

    PubMed  Google Scholar 

  48. Shackelford RE, Bui M, Coppola D, Hakam A (2010) Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers. Int J Clin Exp Pathol 3:522–527

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Lehrke M, Reilly M, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:161–168

    Article  CAS  Google Scholar 

  50. Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (2005) Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 334:1092–1101

    Article  CAS  PubMed  Google Scholar 

  51. Verma S, Li S, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736–740

    Article  CAS  PubMed  Google Scholar 

  52. Yadav A, Kumar B, Datta J, Teknos TN, Kumar P (2011) IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9:1658–1667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Hsieh YY, Shen C, Huang WS, Chin CC, Kuo YH, Hsieh MC, Yu HR, Chang TS, Lin TH, Chiu YW, Chen CN, Kuo HC, Tung SY (2014) Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFkB signaling pathway in gastric cancer cells. J Biomed Sci 21:59

    Article  PubMed  PubMed Central  Google Scholar 

  54. Yang CC, Chang S, Chao JK, Lai YL, Chang WE, Hsu WH, Kuo WH (2014) Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin. BMC Cancer 14:112

    Article  PubMed  PubMed Central  Google Scholar 

  55. Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI, Castan-Laurell I (2007) Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63:359–373

    Article  CAS  PubMed  Google Scholar 

  56. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–1771

    Article  CAS  PubMed  Google Scholar 

  57. Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P (2011) Apelin, diabetes, and obesity. Endocrine 40:1–9

    Article  CAS  PubMed  Google Scholar 

  58. Yoshiya S, Shirabe K, Imai D, Toshima T, Yamashita Y, Ikegami T, Okano S, Yoshizumi T, Kawanaka H, Maehara Y (2015) Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol 50:573–582

    Article  CAS  PubMed  Google Scholar 

  59. Altinkaya SO, Nergiz S, Küçük M, Yüksel H (2015) Apelin levels are higher in obese patients with endometrial cancer. J Obstet Gynaecol Res 41:294–300

    Article  CAS  PubMed  Google Scholar 

  60. Berta J, Hoda M, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B (2014) Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget 5:4426–4437

    Article  PubMed  PubMed Central  Google Scholar 

  61. Goralski KB, McCarthy T, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175–28188

    Article  CAS  PubMed  Google Scholar 

  62. Wittamer V, Franssen J, Vulcano M, Mirjolet JF, Le Poul E, Miggeotte I, Brezillion S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977–985

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Rama D, Esendagli G, Guc D (2011) Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment. Cell Immunol 271:134–140

    Article  CAS  PubMed  Google Scholar 

  64. Wang C, Wu W, Liu X, To KF, Chen GG, Yu J, Ng EK (2014) Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study. Peptides 51:131–138

    Article  CAS  PubMed  Google Scholar 

  65. Zhang J, Jin H, Zhu AK, Ying RC, Wei W, Zhang FJ (2014) Prognostic significance of plasma chemerin levels in patients with gastric cancer. Peptides 61:7–11

    Article  CAS  PubMed  Google Scholar 

  66. Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, Seya T (2001) Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 276:23456–23463

    Article  CAS  PubMed  Google Scholar 

  67. Yang RZ, Lee M, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253–E1261

    Article  CAS  PubMed  Google Scholar 

  68. Ohashi K, Shibata R, Murohara T, Ouchi N (2014) Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab 25:348–355

    Article  CAS  PubMed  Google Scholar 

  69. Smitka K, Marešová D (2015) Adipose tissue as an endocrine organ: an update on proinflammatory and anti-inflammatory microenvironment. Prague Med Rep 116(2):87–111

    Article  PubMed  Google Scholar 

  70. Uyeturk U, Sarıcı H, Kın Tekce B, Eroglu M, Kemahlı E, Uyeturk U, Gucuk A (2014) Serum omentin level in patients with prostate cancer. Med Oncol 31:923

    Article  PubMed  Google Scholar 

  71. Uyeturk U, Alcelik A, Aktas G, Tekce BK (2014) Post-treatment plasma omentin levels in patients with stage III colon carcinoma. J BUON 19:681–685

    PubMed  Google Scholar 

  72. Zhang YY, Zhou L (2013) Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol 698:137–144

    Article  CAS  PubMed  Google Scholar 

  73. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS (2010) Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151:3169–3180

    Article  CAS  PubMed  Google Scholar 

  74. Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G (2012) Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 61:1959–1968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Xu Y, Pang X, Dong M, Wen F, Zhang Y (2013) Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro. Biochem Biophys Res Commun 440:467–472

    Article  CAS  PubMed  Google Scholar 

  76. Wada J (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17:327–333

    Article  CAS  PubMed  Google Scholar 

  77. Blüher M (2012) Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41:176–182

    Article  PubMed  Google Scholar 

  78. Noy N, Li L, Abola MV, Berger NA (2015) Is retinol binding protein 4 a link between adiposity and cancer? Horm Mol Biol Clin Investig 23:39–46

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Nieman KM, Romero IL, Van Houten B, Lengyel E (2013) Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 1831:1533–1541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Nieman KM, Kenny H, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498–1503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Liu Y (2006) Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis 9:230–234

    Article  CAS  PubMed  Google Scholar 

  82. Baron A, Migita T, Tang D, Loda M (2004) Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91:47–53

    Article  CAS  PubMed  Google Scholar 

  83. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I (2014) Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev 33:527–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of Interest

None to declare.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ofer Reizes Ph.D. or Nathan A. Berger M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Saygin, C., Reizes, O., Berger, N.A. (2017). Adipocytes, Adipocytokines, and Cancer. In: Reizes, O., Berger, N. (eds) Adipocytokines, Energy Balance, and Cancer. Energy Balance and Cancer, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-41677-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41677-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41675-5

  • Online ISBN: 978-3-319-41677-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics